objection
发表于 2025-3-28 17:24:30
http://reply.papertrans.cn/23/2230/222902/222902_41.png
迅速飞过
发表于 2025-3-28 20:19:30
Mesenchymal Stem Cells: From Bench to Bedside and Backs the treatment of graft-versus-host disease (GvHD) and marrow failure. The initial studies confirmed the infusional safety of MSC given to HCT recipients and have paved the way for subsequent clinical research. Today, more than a decade later, the potential of MSC to improve outcomes after allogene
思想流动
发表于 2025-3-29 00:37:21
Gene Therapy for Neoplastic Hematology in Transplant Settingcide gene therapies, gene suppression, or oncolytic viral and non-viral therapies. In this chapter, we will review the historical context of gene therapy and cellular engineering development for the treatment of hematological malignancies and, particularly, in the setting of hematopoietic cell trans
ticlopidine
发表于 2025-3-29 06:48:40
Gene Therapy for Nonmalignant Hematologyn of gene-editing platforms, including zinc-finger nuclease (ZFN), transcription activator-like effector nucleases (TALEN), and clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9, offer exciting prospective strategies for further improving gene therapy by targeting the repair of
半身雕像
发表于 2025-3-29 10:34:47
https://doi.org/10.1057/978-1-137-57085-7heless, the attractions of a component therapy approach to HCT are many including but not limited to (1) T-cell depletion by selection of CD34. cells, which can reduce GvHD, and (2) infused donor lymphocytes which can improve engraftment and treat leukemic relapse. Careful studies in the 1990s deter
induct
发表于 2025-3-29 12:20:12
http://reply.papertrans.cn/23/2230/222902/222902_46.png
擦试不掉
发表于 2025-3-29 17:56:43
http://reply.papertrans.cn/23/2230/222902/222902_47.png
发现
发表于 2025-3-29 20:28:04
http://reply.papertrans.cn/23/2230/222902/222902_48.png
牙齿
发表于 2025-3-30 01:43:19
,Conclusion: The Ombuds as “Third Way”,the deficiencies in viral immunity post-transplant. In this review, we begin by detailing the advances made in producing single-virus-specific T cells, in particular for CMV and EBV, and then proceed to describe the progress in developing multi-virus-specific T cells and in broadening the repertoire
诱拐
发表于 2025-3-30 06:33:04
http://reply.papertrans.cn/23/2230/222902/222902_50.png